This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Attendees were encouraged to engage in several talks and presentations throughout the day, and the event organizers had done a fantastic job assembling an outstanding lineup of speakers/key industry leaders to spark extensive discussions. Of all the high-quality presentations I attended, two in particular caught my attention.
This heterogeneity, present within the same structure or between various organoids, could complicate our understanding of specific mechanisms of action when testing novel drugs in vitro. Prior to joining Beckman Coulter Life Sciences, she worked as a Research Associate and Postdoctoral Fellow at Indiana University School of Medicine.
Dr Alani also directs a clinical program at Boston Medical Center focused on patients with melanoma and other high-risk skin cancers and has been recognized as a 2024 Boston Magazine and Castle Connolly Top Doctor. Dr Alani further developed her research interests as a research fellow at Memorial Sloan-Kettering Cancer Center.
Progress in molecularbiology and translational science. References Juganavar, A., Joshi, A., & Shegekar, T. 2023, September 9). Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia. link] Pugazhenthi, S. 2017, February 4). Metabolic syndrome and the cellular phase of alzheimer’s disease.
3 The use of transposon-based systems significantly reduces risks of integrating bacterial elements present on the transposon vector, since integration of the gene is catalysed by the transposase only upon recognition of the inverted terminal repeats (ITRs) flanking the gene of interest and the selection cassette.
During my doctoral training, I split my work between wet lab research and programming, two streams that differed radically in terms of productivity. One could speculate that placing these cell-splitting genes near the origin might ensure they are always present at an adequate concentration to split cells and thus speed up cell division.
coli in urinary tract infections, Garofolo says they achieved a 6-log reduction in bacterial numbers in patients (meaning the number of bacterial cells present has been reduced a million-fold), leading to “100 percent clinical cure” of all 31 patients. In a trial of their most advanced asset, a phage mixture targeting E.
in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. “The first printout of the human genome to be presented as a series of books, displayed in the 'Medicine Now' room at the Wellcome Collection, London. All the colors had the same brightness. From McKyton et al.
in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. “The first printout of the human genome to be presented as a series of books, displayed in the 'Medicine Now' room at the Wellcome Collection, London. All the colors had the same brightness. From McKyton et al.
His advisor marched him down to the office of a new faculty member, Tobin Sosnick, who is now chair of the Department of Biochemistry and MolecularBiology at the University of Chicago. Bhattacharyya’s work in Sosnick’s lab solidified his interests in biology and biochemistry, but he also had a growing desire to practice medicine.
In 1929 and 1930, two medical doctors working with Cohn — George R. Some field strategists — such as Salvador Luria, in the case of molecularbiology — have a warm personality that draws individuals into a field. Minot and William P. Nonetheless, one visitor to the Harvard lab, A.C. Credit: Surgenor, page 198.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content